u Aprogenex Inc., Houston, acquired the U.S. patent titled "One Step InSitu Hybridization," issued in July 1993, from the Clayton Foundationfor Research, Houston.u InflaZyme Pharmaceuticals Ltd., Vancouver, British Columbia,received notice for allowance on its U.S. patent on phosphonate(Fitofosine) as an anti-cancer agent.u Incyte Pharmaceuticals Inc., Palo Alto, Calif., was issued U.S. patentNo. 5,334,584 covering compositions and methods directed torecombinant non-glycosylated forms of bacterial permeabilityincreasing protein.

(c) 1997 American Health Consultants. All rights reserved.